A Paradigm Shift in the Assessment of Musculoskeletal Rehabilitation After Anterior Cruciate Ligament Reconstruction: Protocol for a Multicenter Case-Control Cross-Sectional Study Using Near-Infrared Spectroscopy (HemoNIRS-LCA)
A Paradigm Shift in the Assessment of Musculoskeletal Rehabilitation After Anterior Cruciate Ligament Reconstruction: Protocol for a Multicenter Case-Control Cross-Sectional Study Using Near-Infrared Spectroscopy (HemoNIRS-LCA)
This study aims to establish and compare muscle haemodynamic response patterns in physically active subjects with anterior cruciate ligament (ACL) reconstruction, at different time points after surgery, against healthy controls, using 24 non-invasive near-infrared spectroscopy (NIRS) devices simultaneously during a single incremental interval cycling test.
Muscle haemodynamics has so far been assessed using at most 2-3 near-infrared spectroscopy devices on isolated muscles and without correlating variables. At the same time, research on musculoskeletal pathologies is limited, and there are no studies that analyse the haemodynamic changes that occur when the anterior cruciate ligament (ACL) is injured and whether these changes last over time.
This is a multicentre, observational, case-control, cross-sectional study, approved by the Clinical Research Ethics Committee of the Arnau de Vilanova University Hospital (CEIC-3203), that will include males aged 18-65 years who have undergone ACL reconstruction, divided into three groups: less than 6 months since surgery (ACL1), more than 2 years since surgery with normalised physical activity (ACL2), and a healthy control group with no history of ACL injury. Recruitment has not yet started and is expected to begin in October 2026
Assessment of muscle haemodynamics after musculoskeletal injury has traditionally relied on a limited number of near-infrared spectroscopy (NIRS) sensors placed on isolated muscles, without a simultaneous, multi-site approach. This study addresses that methodological gap in the context of anterior cruciate ligament (ACL) reconstruction.
This study aims to establish and compare muscle haemodynamic response patterns, measured using NIRS, in physically active individuals with ACL reconstruction at different time points after surgery, compared with healthy controls.
It is a multicentre, observational, case-control, cross-sectional study, conducted in three groups of males aged 18 to 65 years: ACL1 (less than 6 months since ACL reconstruction), ACL2 (more than 2 years since ACL reconstruction, with normalised physical activity and no longer undergoing rehabilitation), and a healthy control group with no history of ACL injury.
Each participant completes a single incremental interval cycling test on a cycle ergometer. During the test, 24 portable NIRS devices (Moxy) simultaneously and bilaterally record haemodynamic data at 12 muscle locations: rectus femoris (proximal and distal thirds), vastus medialis, vastus lateralis, biceps femoris (proximal and distal thirds), semitendinosus, gluteus maximus, tibialis anterior, gastrocnemius, medial deltoid, and biceps brachii; combining propulsive, stabilising, and postural musculature and reflecting a multi-joint, whole-body approach to the assessment of exercise-induced muscle haemodynamics.. Data are analysed using a proprietary multiparametric interpretation algorithm designed to evaluate the haemodynamic performance of multiple muscle groups simultaneously and comparatively. Assessors and statisticians remain blinded to group assignment throughout data collection and analysis.
Primary outcomes are muscle oxygen saturation, capillary haemoglobin concentration, and muscle blood flow, recorded continuously via NIRS at each of the 12 bilateral locations during exercise and through 2 to 3 minutes of post-exercise recovery (an individually variable recovery period). Secondary outcomes include heart rate (continuous Bluetooth monitoring), rating of perceived exertion (Borg CR-10 scale, 0-10), anthropometric and adiposity indicators (height, weight and body mass index), sociodemographic and clinical variables (age, toxic habits, injury and sports history, and physical activity in the preceding 48 to 72 hours), and study dropouts with their reason.
Sample size was calculated using G-Power, based on a moderate effect size (Cohen's d = 0.5) estimated from a study in the process of publication, with a 95% confidence level (Z = 1.96), 80% statistical power (β = 0.20), and a 10% non-response rate, yielding a required sample of 43 participants per group (total n = 129).
The study is conducted at four collaborating centers: Espai Físic de Salut Integral, Fisioplanet, Hospital Universitari Son Espases (HUSE), and Sant Joan de Déu Palma-Inca (SJD). It is approved by the Clinical Research Ethics Committee of the Arnau de Vilanova University Hospital (CEIC-3203)
General inclusion criteria
General exclusion criteria
Eligibility criteria (LCA1 group)
Eligibility criteria (LCA2 group)
Eligibility criteria (CON group)
xisco.verdejo@udl.cat+34 670729376
oriol.martinez@udl.cat+34 619562618
Palma de Mallorca, Balearic Islands 07015, Spain
xisco.verdejo@udl.cat+34 973702459